Articles
  

The Effect of Candida Albicans Systemic Infection on Matrix Metalloproteinases in Breast Cancer Bearing Balb/c Mice

Abstract

Breast cancer  patients  are  susceptible to  infections such  as  candidiasis. Due  to  the importance and the role of matrix metalloproteinases (MMP) in breast cancer progression and its correlation with tumor metastasis, we analyzed the serum level of MMPs -2, -3, -9 and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in breast cancer bearing mice in the presence of systemic Candida albicans infection.
Female BALB/c  mice were divided into 4 groups:  group I had tumor  +  candidiasis; group II, tumor only; group III, candidiasis only and group IV as negative control. Tumor tissue was separated from stock breast cancer bearing mice and transplanted subcutaneously into the groups I and II mice. Two weeks after tumor transplantation, groups I and III were infected with Candida albicans by intravenous injection. One week after systemic infection, the sera of the experimental groups were prepared and analyzed with ELISA for MMP-2, -3, -9 and TIMP-1 levels.
The results showed that the levels of MMP-3, MMP-9 and TIMP-1 were increased in groups I, II and III, as compared to the control group. However, the level of MMP-2 was decreased in mice infected with Candida albicans and in infected mice bearing tumor.
These data suggest that candidiasis may have a positive effect on tumor progression and metastasis.

1. Rodier MH, el Moudni B, Kauffmann-Lacroix C, Daniault G, Jacquemin JL. A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix. FEMS Microbiol Lett 1999;177(2):205-10.
2. Wisplinghoff H, Cornely OA, Moser S, Bethe U, Stützer H, Salzberger B, et al. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infect Control Hosp Epidemiol 2003; 24(12):905-11.
3. Pasqualotto AC, Rosa DD, Medeiros LR, Severo LC.Candidaemia and cancer: patients are not all the same. BMC Infect Dis 2006; 6(50):1471-2334.
4. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 2006; 119(6):1403-11.
5. Agnantis NJ, Goussia AC, Stefanou D. Tumor markers.An update approach for their prognostic significance. PartI. In Vivo 2003; 17(6):609-18.
6. Liu SC, Yang SF, Yeh KT, Yeh CM, Chiou HL, Lee CY, et al. Relationships between the level of matrix metalloproteinase-2 and tumor size of breast cancer. Clin Chim Acta 2006; 371(1–2):92-6.
7. Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C, et al.Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat 2007; 103(3):319-29.
8. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005; 9(2):267-85.
9. Vihinen P, Ala-aho R, Kahari VM. Matrix metalloproteinases as therapeutic targets in cancer. Curr Cancer Drug Targets 2005; 5(3):203-20.
10. La Rocca G, Pucci-Minafra I, Marrazo A, Taormina P, Minafra S. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer 2004; 90(7):1414–21.
11. Di Carlo A. Matrix metalloproteinase-2 and matrix metalloproteinase-9 type IV collagenases in serum of patients with pleural effusions. Int J Oncolog 2005; 26(5):1363-8.
12. Rio MC, Lefebvre O, Santavicca M, Noël A, Chenard MP, Anglard P, et al. Stromelysin-3 in the biology of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1996; 1(2):231-40.
13. Nakopoulou L, Giannopoulou I, Stefanaki K, Panayotopoulou E, Tsirmpa I, Alexandrou P, et al.
.Enhanced mRNA expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) in breast carcinomas is correlated with adverse prognosis. J Pathol 2002;197(3):307–13.

14. Yoshiji H, Gomez DE, Thorgeirsson UP. Enhanced RNA expression of tissue inhibitor of metalloproteinases- 1 (TIMP-1) in human breast cancer. Int J Cancer 1996;69(2):131–4.
15. Olishevsky S, Burlaka A, Sidorik E, Shlyakhovenko V, Garpenko Y, Kozak V. Modulation of Ros/No production by murine peritoneal macrophages in response to bacterial CpG DNA stimulation . Exp Oncol 2006;28(2):114-20.
16. Jacob MP. Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions. Biomed Pharmacother 2003;57(5-6):١95–202.
17. Al Haj Zen A, Lafont A, Durand E, Brasselet C, Lemarchand P, Godeau G, et al. Effect of adenovirus- mediated overexpression of decorin on metalloproteinases, tissue inhibitors of metalloproteinases and cytokines secretion by human gingival fibroblasts. Matrix Biol 2003; 22(3):251-8.
18. Talvensaari-Mattila A, Paakko P, Blanco-Sequeiros G.Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with anti-estrogen adjuvant therapy. Breast Cancer Res Treat 2001; 65(1):55-61.
19. Claveau I, Mostefaoui Y, Rouabhia M. Basement membrane protein and matrix metalloproteinase deregulation in engineered human oral mucosa following infection with Candida albicans. Matrix Biol2004;23(7):477-86.
20. Imbert C, Kauffmann-Lacroix C, Daniault G, Jacquemin JL, Rodier MH. Effect of matrix metalloprotease inhibitors on the 95 kDa metallopeptidase of Candida albicans. J Antimicrob Chemother 2002; 49(6):1007-10.
21. Martin MD, Carter KJ, Jean-Philippe SR, Chang M,Mobashery S, Thiolloy S, et al. Effect of ablation or inhibition of stromal matrix metalloproteinase-9 on lung metastasis in a breast cancer model is dependent on genetic background. Cancer Res 2008; 68(15):6251–9.
22. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, Taraboletti G, Giavazzi R. Matrix metalloproteinases (mmp9 and mmp2) induce the release of vascular endothelial growth factor (vegf) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 2003; 63: 5224–9.

Files
IssueVol 12, No 1 (2013) QRcode
SectionArticles
Keywords
Breast cancer Candida albicans Candidiasis Matrix metalloproteinase (MMP) Metastasis Tissue inhibitor of matrix metalloproteinase (TIMP)
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Hajari Taheri F, Seyedolmohadesin M, Bayat M, Mahdavi M, Yazdi MH, Eslamifar A, Abolhasani M. The Effect of Candida Albicans Systemic Infection on Matrix Metalloproteinases in Breast Cancer Bearing Balb/c Mice. Iran J Allergy Asthma Immunol. 1;12(1):81-85.